clofazimine has been researched along with Obesity in 1 studies
Clofazimine: A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
clofazimine : 3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scagliola, A | 1 |
| Miluzio, A | 1 |
| Ventura, G | 1 |
| Oliveto, S | 1 |
| Cordiglieri, C | 1 |
| Manfrini, N | 1 |
| Cirino, D | 1 |
| Ricciardi, S | 1 |
| Valenti, L | 1 |
| Baselli, G | 1 |
| D'Ambrosio, R | 1 |
| Maggioni, M | 1 |
| Brina, D | 1 |
| Bresciani, A | 1 |
| Biffo, S | 1 |
1 other study available for clofazimine and Obesity
| Article | Year |
|---|---|
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Cell Transformat | 2021 |